Cargando…

Impact of Multidrug-resistant Enterobacteriaceae Bloodstream Infections in Children

BACKGROUND: Antibiotic resistance is a serious and growing concern worldwide. Although Enterobacteriaceae bloodstream infections (BSI) are severe, little is known regarding the impact of multidrug resistance (MDR) on children. This study aimed to describe the clinical and microbiological features of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aizawa, Yuta, Yoneda, Ryu, Funakoshi, Hanako, Ishii, Sho, Araki, Kotaro, Murai, Takemi, Fukuoka, Kahoru, Horikoshi, Yuho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631448/ http://dx.doi.org/10.1093/ofid/ofx163.1816

Ejemplares similares

Antimicrobial Stewardship Program for Broad-Spectrum Oral Antibiotic Use in a Pediatric Emergency Department: an Interrupted Time-Series Analysis
por: Fukuoka, Kahoru, et al.
Publicado: (2017)

2334. Risk Factors of Multidrug-Resistant Gram-Negative Bacterial Bloodstream Infections in Children’s Hospitals in Japan
por: Aizawa, Yuta, et al.
Publicado: (2018)

1148. Antimicrobial Stewardship Program at a Long-term Care Hospital for Severely Handicapped Children and Adults
por: Ishii, Sho, et al.
Publicado: (2019)

1917. Diagnostic Errors in Bacterial Osteomyelitis in Children
por: Otani, Yuki, et al.
Publicado: (2018)

2144. Duration of perioperative antibiotic prophylaxis in ventriculoperitoneal shunt surgery in children
por: Tada, Ayumi, et al.
Publicado: (2022)

969 Macrolide resistant mycoplasma did not have worse clinical course in children's hospital in Japan
por: Funakoshi, Yu, et al.
Publicado: (2014)

1447. Emergence of Avibactam Resistance in Multidrug-Resistant Enterobacteriaceae
por: Brennan-Krohn, Thea, et al.
Publicado: (2020)

1144. Dissociative Neurological Symptom Reactions Following COVID-19 Vaccination in Adolescents in Japan
por: Horikoshi, Yuho, et al.
Publicado: (2023)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

1618. Meropenem-vaborbactam vs standard of care for multidrug resistant carbapenem-resistant Enterobacteriaceae
por: Misikir, Helina, et al.
Publicado: (2020)

284. Evaluation of Oral Step-Down Therapy for Enterobacteriaceae Bloodstream Infection
por: Utley, Sara, et al.
Publicado: (2020)

1811. Minimizing Time to Optimal Therapy for Enterobacteriaceae Bloodstream Infections: Is Organism Identification Enough?
por: Cwengros, Laura N, et al.
Publicado: (2018)

2076. Intestinal colonization with multidrug-resistant organisms, horizontal transmission and risk for bloodstream infection
por: Karakosta, Polyxeni, et al.
Publicado: (2023)

Use of a Precision Antibiotic Therapy (PAT) Prediction Model to Identify Multidrug-Resistant (MDR) Enterobacteriaceae
por: Varga, Alexandra, et al.
Publicado: (2017)

2800. Carbapenem Resistant Enterobacteriaceae bloodstream infections in children from Latin America & Caribbean region: systematic review and meta-analysis
por: Ruvinsky, Silvina, et al.
Publicado: (2023)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

1185. Impact of Bloodstream Infections Caused by Multidrug-resistant Organisms on Performance Status: A KARS-Net Study
por: Huh, Kyungmin, et al.
Publicado: (2018)

1964. Microbiological Outcomes With Plazomicin (PLZ) vs. Colistin (CST) in Patients With Bloodstream Infections (BSI) Caused by Carbapenem-Resistant Enterobacteriaceae (CRE) in the CARE Study
por: Serio, Alisa W, et al.
Publicado: (2018)

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae
por: Li, Xiaopeng, et al.
Publicado: (2017)

Antimicrobial Resistance of Enterobacteriaceae in Bloodstream Infections in Hospitalized Patients in Southern Poland
por: Kłos, Marta, et al.
Publicado: (2022)

Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: a Patient-level Analysis of Published Data
por: O’Donnell, J Nicholas, et al.
Publicado: (2017)

1046. Clinical and Microbiological Characteristics of Patients With Septicemia Caused by IMP-1-Producing Enterobacteriaceae in a Tertiary Hospital in Japan
por: Mori, Nobuaki, et al.
Publicado: (2018)

Orthopedic Implant-Associated Infection by Multidrug Resistant Enterobacteriaceae
por: Pfang, Bernadette G., et al.
Publicado: (2019)

Multidrug-resistant enterobacteriaceae in coastal water: an emerging threat
por: Cohen, Regev, et al.
Publicado: (2020)

The Prevalence of Multidrug-Resistant Enterobacteriaceae among Neonates in Kuwait
por: Alajmi, Rehab Zafer, et al.
Publicado: (2023)

Hospital-acquired enterobacteriaceae Bloodstream Infections in Children
por: Kłos, Marta, et al.
Publicado: (2019)

1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
por: Saito, Sho, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

2435. Clinical Outcomes With Ceftolozane–Tazobactam in Patients With Multidrug-Resistant (MDR) Pseudomonas aeruginosa Bloodstream Infections: A Multi-Center Study
por: King, Madeline, et al.
Publicado: (2018)

Multidrug-Resistant and Carbapenemase-Producing Enterobacteriaceae in Addis Ababa, Ethiopia
por: Tekele, Saba Gebremichael, et al.
Publicado: (2021)

503. Comparison of IMP Carbapenemase-Producing Enterobacteriaceae (CPE) and Non-Carbapenemase-Producing Enterobacteriaceae: A Multicenter Prospective Study of Clinical and Molecular Epidemiology in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2019)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

2266. Management of Ertapenem-Resistant, Meropenem-Susceptible Enterobacteriaceae
por: Srinivas, Pavithra, et al.
Publicado: (2019)

2446. Clinical Spectrum and Outcomes of Colistin-Resistant Carbapenem-Resistant Enterobacteriaceae
por: Ahmed, Sara, et al.
Publicado: (2018)

621. In vitro Ceftazidime: Avibactam Resistance in Carbapenem-Resistant Enterobacteriaceae Isolates
por: Belal, Maymonah, et al.
Publicado: (2019)

Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States (US) Medical Centers (2013–2016)
por: Sader, Helio S, et al.
Publicado: (2017)

1694. Joint Fluid Cell Count of Septic Arthritis Patients Diagnosed with Positive Culture in Children
por: Otsubo, Yuto, et al.
Publicado: (2023)

Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection
por: Ahn, Jin Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3tkfto1lb3shslm272cop1dvh